
James C. Yeung
Examiner (ID: 15138)
| Most Active Art Unit | 3406 |
| Art Unit(s) | 3401, 3749, 3105, 3743, 3404, 3405, 3406, 2899 |
| Total Applications | 2326 |
| Issued Applications | 2124 |
| Pending Applications | 58 |
| Abandoned Applications | 144 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19382307
[patent_doc_number] => 20240272177
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-15
[patent_title] => sFRP4 AS BLOOD BIOMARKER FOR THE NON-INVASIVE DIAGNOSIS OF ADENOMYOSIS
[patent_app_type] => utility
[patent_app_number] => 18/561621
[patent_app_country] => US
[patent_app_date] => 2022-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12640
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18561621
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/561621 | sFRP4 AS BLOOD BIOMARKER FOR THE NON-INVASIVE DIAGNOSIS OF ADENOMYOSIS | May 15, 2022 | Pending |
Array
(
[id] => 19114051
[patent_doc_number] => 20240125801
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-18
[patent_title] => MARKER FOR DIAGNOSIS OF NONALCOHOLIC FATTY LIVER DISEASE
[patent_app_type] => utility
[patent_app_number] => 18/276218
[patent_app_country] => US
[patent_app_date] => 2022-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9558
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18276218
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/276218 | MARKER FOR DIAGNOSIS OF NONALCOHOLIC FATTY LIVER DISEASE | May 12, 2022 | Pending |
Array
(
[id] => 17838954
[patent_doc_number] => 20220276259
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => METHODS FOR DIAGNOSING SYSTEMIC LUPUS ERYTHEMATOSUS
[patent_app_type] => utility
[patent_app_number] => 17/743289
[patent_app_country] => US
[patent_app_date] => 2022-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18053
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17743289
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/743289 | METHODS FOR DIAGNOSING SYSTEMIC LUPUS ERYTHEMATOSUS | May 11, 2022 | Abandoned |
Array
(
[id] => 17831488
[patent_doc_number] => 20220268792
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-25
[patent_title] => COMPOSITIONS AND METHODS FOR THE DETECTION OF HOST CELL PROTEINS
[patent_app_type] => utility
[patent_app_number] => 17/735555
[patent_app_country] => US
[patent_app_date] => 2022-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22465
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17735555
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/735555 | COMPOSITIONS AND METHODS FOR THE DETECTION OF HOST CELL PROTEINS | May 2, 2022 | Pending |
Array
(
[id] => 17831487
[patent_doc_number] => 20220268791
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-25
[patent_title] => COMPOSITIONS AND METHODS FOR THE DETECTION OF HOST CELL PROTEINS
[patent_app_type] => utility
[patent_app_number] => 17/735524
[patent_app_country] => US
[patent_app_date] => 2022-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22453
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17735524
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/735524 | Compositions and methods for the detection of host cell proteins | May 2, 2022 | Issued |
Array
(
[id] => 20454076
[patent_doc_number] => 12517128
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-01-06
[patent_title] => Sample collection and analysis
[patent_app_type] => utility
[patent_app_number] => 17/735836
[patent_app_country] => US
[patent_app_date] => 2022-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 0
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 268
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17735836
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/735836 | Sample collection and analysis | May 2, 2022 | Issued |
Array
(
[id] => 20069913
[patent_doc_number] => 20250208135
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-06-26
[patent_title] => Biomarkers for Neurodegenerative Disease
[patent_app_type] => utility
[patent_app_number] => 18/557941
[patent_app_country] => US
[patent_app_date] => 2022-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16907
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18557941
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/557941 | Biomarkers for Neurodegenerative Disease | Apr 27, 2022 | Pending |
Array
(
[id] => 19136461
[patent_doc_number] => 11971407
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-30
[patent_title] => Detection of anti-p53 antibodies
[patent_app_type] => utility
[patent_app_number] => 17/730403
[patent_app_country] => US
[patent_app_date] => 2022-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5882
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17730403
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/730403 | Detection of anti-p53 antibodies | Apr 26, 2022 | Issued |
Array
(
[id] => 17983869
[patent_doc_number] => 20220349905
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-03
[patent_title] => METHODS AND DEVICES FOR QUANTITATIVELY ESTIMATING SYNDECAN-1
[patent_app_type] => utility
[patent_app_number] => 17/715294
[patent_app_country] => US
[patent_app_date] => 2022-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3011
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17715294
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/715294 | Methods and devices for quantitatively estimating syndecan-1 | Apr 6, 2022 | Issued |
Array
(
[id] => 20220961
[patent_doc_number] => 20250283892
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-09-11
[patent_title] => DIAGNOSIS OF ALZHEIMER'S DISEASE BY DETECTING AUTO-ANTIBODIES AGAINST Y-BOX BINDING PROTEIN-1 (YB-1)
[patent_app_type] => utility
[patent_app_number] => 18/551454
[patent_app_country] => US
[patent_app_date] => 2022-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2244
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18551454
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/551454 | DIAGNOSIS OF ALZHEIMER'S DISEASE BY DETECTING AUTO-ANTIBODIES AGAINST Y-BOX BINDING PROTEIN-1 (YB-1) | Mar 21, 2022 | Pending |
Array
(
[id] => 17721643
[patent_doc_number] => 20220214365
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-07
[patent_title] => Methods of Detecting Anti-folic acid Antibodies and Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 17/699706
[patent_app_country] => US
[patent_app_date] => 2022-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16088
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17699706
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/699706 | Methods of detecting anti-folic acid antibodies and uses thereof | Mar 20, 2022 | Issued |
Array
(
[id] => 19061224
[patent_doc_number] => 11940450
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-26
[patent_title] => Biomarker panel for non-invasive diagnosis of congenital renal dysfunction
[patent_app_type] => utility
[patent_app_number] => 17/695381
[patent_app_country] => US
[patent_app_date] => 2022-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 7
[patent_no_of_words] => 8368
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17695381
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/695381 | Biomarker panel for non-invasive diagnosis of congenital renal dysfunction | Mar 14, 2022 | Issued |
Array
(
[id] => 17706009
[patent_doc_number] => 20220206015
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => MARKER FOR STATIN TREATMENT STRATIFICATION IN HEART FAILURE
[patent_app_type] => utility
[patent_app_number] => 17/693789
[patent_app_country] => US
[patent_app_date] => 2022-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28674
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 175
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17693789
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/693789 | MARKER FOR STATIN TREATMENT STRATIFICATION IN HEART FAILURE | Mar 13, 2022 | Abandoned |
Array
(
[id] => 17674157
[patent_doc_number] => 20220187324
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-16
[patent_title] => MULTIPLEXED DIAGNOSTIC TO RECOGNIZE CONCENTRATIONS OF RELATED PROTEINS AND PEPTIDES
[patent_app_type] => utility
[patent_app_number] => 17/684296
[patent_app_country] => US
[patent_app_date] => 2022-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12072
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17684296
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/684296 | MULTIPLEXED DIAGNOSTIC TO RECOGNIZE CONCENTRATIONS OF RELATED PROTEINS AND PEPTIDES | Feb 28, 2022 | Abandoned |
Array
(
[id] => 19608891
[patent_doc_number] => 12157757
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-03
[patent_title] => Cation exchange chromatography methods
[patent_app_type] => utility
[patent_app_number] => 17/679640
[patent_app_country] => US
[patent_app_date] => 2022-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5399
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 146
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17679640
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/679640 | Cation exchange chromatography methods | Feb 23, 2022 | Issued |
Array
(
[id] => 19275493
[patent_doc_number] => 12025616
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-02
[patent_title] => Method and composition for detection of proteolytic products and diagnosis of malignant neoplastic disease
[patent_app_type] => utility
[patent_app_number] => 17/679493
[patent_app_country] => US
[patent_app_date] => 2022-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6854
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17679493
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/679493 | Method and composition for detection of proteolytic products and diagnosis of malignant neoplastic disease | Feb 23, 2022 | Issued |
Array
(
[id] => 18583249
[patent_doc_number] => 20230265509
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-24
[patent_title] => NOVEL TARGETS FOR THE TREATMENT AND DIAGNOSIS OF PATIENTS WITH ATHEROSCLEROSIS AND ENHANCED RISK OF END ORGAN DAMAGE
[patent_app_type] => utility
[patent_app_number] => 17/676072
[patent_app_country] => US
[patent_app_date] => 2022-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18412
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17676072
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/676072 | NOVEL TARGETS FOR THE TREATMENT AND DIAGNOSIS OF PATIENTS WITH ATHEROSCLEROSIS AND ENHANCED RISK OF END ORGAN DAMAGE | Feb 17, 2022 | Abandoned |
Array
(
[id] => 17628525
[patent_doc_number] => 20220163540
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => DETECTION OF GLUCURONIDATED AND 3-BROMOTYROSINE
[patent_app_type] => utility
[patent_app_number] => 17/668261
[patent_app_country] => US
[patent_app_date] => 2022-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7347
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17668261
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/668261 | Detection of glucuronidated and 3-bromotyrosine | Feb 8, 2022 | Issued |
Array
(
[id] => 19014184
[patent_doc_number] => 11921108
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-05
[patent_title] => Methods for determining amount of functional albumin
[patent_app_type] => utility
[patent_app_number] => 17/667376
[patent_app_country] => US
[patent_app_date] => 2022-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 10218
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 212
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17667376
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/667376 | Methods for determining amount of functional albumin | Feb 7, 2022 | Issued |
Array
(
[id] => 20273050
[patent_doc_number] => 12442826
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-14
[patent_title] => Lateral flow test strip readers, cartridges and related methods
[patent_app_type] => utility
[patent_app_number] => 17/590325
[patent_app_country] => US
[patent_app_date] => 2022-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 22
[patent_no_of_words] => 11109
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 196
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17590325
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/590325 | Lateral flow test strip readers, cartridges and related methods | Jan 31, 2022 | Issued |